A Study of Adoptive Immunotherapy With Autologous Tumor Infiltrating Lymphocytes in Solid Tumors

NCT01462903 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Carcinoma
Hepatocellular Carcinoma
Breast Carcinoma

Interventions

BIOLOGICAL: tumor infiltrating lymphocytes, IL-2

Sponsor

Sun Yat-sen University